DUBLIN, IRELAND--(Marketwire - March 06, 2009) - Trinity Biotech plc (NASDAQ: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will report financial results for the fourth quarter and fiscal year 2008 on Tuesday, March 10, 2009. The Company has scheduled a conference call for that same day, Tuesday, March 10, 2009, at 12:00pm ET (4:00pm GMT) to discuss the results of the quarter.
Interested parties can access the call by dialing:
USA: 1-877-356-5706 International: 1-706-679-3820
A simultaneous webcast of the call can be accessed at: http://www.videonewswire.com/event.asp?id=56615
A replay of the call can be accessed until March 13, 2009 by dialing:
USA: 1-800-642-1687 International: 1-706-645-9291 Conference ID #: 88797617
The webcast of the call will be available for 30 days at: http://www.videonewswire.com/event.asp?id=56615
About Trinity Biotech plc
Headquartered in Wicklow, Ireland, Trinity Biotech develops, acquires manufactures and markets over 500 diagnostic products for the point-of-care and clinical laboratory segments of the diagnostic market. The broad line of test kits are used to detect infectious diseases, sexually transmitted diseases, blood coagulation disorders, and autoimmune diseases. Trinity Biotech sells worldwide in over 80 countries through its own sales force and a network of international distributors and strategic partners.
For further information please see the company’s website: http://www.trinitybiotech.com.
Contact:
Ms. Niamh Long
Trinity Biotech plc
Investor Relations Officer
(353 1) 276 9800
Joe Diaz, Joe Dorame and Robert Blum
Lytham Partners, LLC
602-889-7900
